Recently, there has been an increased incidence of HCC attributed to non-alcoholic fatty liver disease in Europe and the United States, and about 40% of HCC has been linked with aflatoxins and p53 mutations in regions such as Africa and China [3]. The gene discussed is TP53; the disease is hepatocellular carcinoma.